What Medicare Drug Negotiation Means for Patients in 2026 and Beyond
As we rang in the new year, we passed a significant milestone in the Medicare Negotiation Program. Quietly and without much fanfare, the Maximum Fair Prices (MFPs) for the first…
CCPA Responds to CMS Drug Price Negotiation Announcement (IPAY 2028)
Liz Helms, Founder and Director of the Chronic Care Policy Alliance (CCPA), issued the following statement in response to the announcement of the list of medications subject to Medicare Drug…
CCPA Submits Letters to Congress Ahead of Insurance Hearings
Today, the Chronic Care Policy Alliance (CCPA) submitted two letters to congressional committees ahead of hearings examining insurance practices and their impact on patients living with chronic and serious health…